Copper/cholesterol interaction in Alzheimer's Disease

Ashley Bush, MD, PhD
Mental Health Researrch Institute of Victoria (Parkville, Victoria, Australia)
Year Awarded:
Grant Duration:
April 1, 2005 to March 31, 2007
Alzheimer's Disease
Award Amount:
Grant Reference ID:
Award Type:
Award Region:

Copper/cholesterol interaction in Alzheimer's Disease


In Alzheimer's disease a normal protein called beta-amyloid (Aβ) has been found to accumulate abnormally in the brain. AD has also been associated with abnormalities in cholesterol metabolism. Both links, however, are complex and the results of their specific effects have not yet been pin-pointed. Dr. Bush's team has discovered Aβ to be a copper binding protein. Copper (like cholesterol) is a normally abundant part of brain chemistry, but in AD Aβ abnormally utilizes copper's chemical energy to convert cholesterol into hydrogen peroxide. This is a damaging reaction that may be the cause of the toxicity of Aβ. Through a five part research analysis, Dr. Bush's studies will help illuminate the complex biochemistry of Aβ in its reactions with copper and cholesterol in the brain.


Adlard, P. and Bush, A.I. (2006) Metals and Alzheimer's disease. Journal of Alzheimer's disease. 10(2-3):145-163.  

Frederickson, C.J., Koh, J.Y., Bush, A.I. (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci. Jun;6(6):449-62  

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.